Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Breast Cancer Research and Treatment
Published in: Breast Cancer Research and Treatment 3/2000

01-08-2000

Formestane is feasible and effective in elderly breast cancer patients with comorbidity and disability

Authors: Antonella Venturino, Danila Comandini, Cristina Granetto, Riccardo Alberto Audisio, Federico Castiglione, Riccardo Rosso, Lazzaro Repetto

Published in: Breast Cancer Research and Treatment | Issue 3/2000

Login to get access
Metadata
Title
Formestane is feasible and effective in elderly breast cancer patients with comorbidity and disability
Authors
Antonella Venturino
Danila Comandini
Cristina Granetto
Riccardo Alberto Audisio
Federico Castiglione
Riccardo Rosso
Lazzaro Repetto
Publication date
01-08-2000
Publisher
Kluwer Academic Publishers
Published in
Breast Cancer Research and Treatment / Issue 3/2000
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1023/A:1006490524736

Other articles of this Issue 3/2000

Breast Cancer Research and Treatment 3/2000 Go to the issue

OriginalPaper

Role of MAP kinase in the enhanced cell proliferation of long term estrogen deprived human breast cancer cells

OriginalPaper

Carcinoma in situ of the female breast. 10 year follow-up results of a prospective nationwide study

OriginalPaper

Pre-existent immunity to the HER-2/neu oncogenic protein in patients with HER-2/neu overexpressing breast and ovarian cancer

Authors Index

Subject Index, Volume 62

OriginalPaper

Growth arrest and cell death in the breast tumor cell in response to ionizing radiation and chemotherapeutic agents which induce DNA damage

OriginalPaper

99m-Tc-tetrofosmin scintigraphy for the evaluation of suspicious palpable and non-palpable breast lesions
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits